Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 4
1966 1
1967 5
1968 2
1969 5
1970 1
1971 3
1972 3
1973 6
1974 7
1975 2
1976 9
1977 2
1978 6
1979 5
1980 2
1981 9
1982 3
1983 4
1984 13
1985 4
1986 3
1987 9
1988 11
1989 7
1990 17
1991 14
1992 13
1993 12
1994 13
1995 12
1996 11
1997 11
1998 9
1999 7
2000 11
2001 6
2002 11
2003 23
2004 11
2005 23
2006 13
2007 8
2008 16
2009 14
2010 15
2011 7
2012 10
2013 11
2014 8
2015 13
2016 10
2017 11
2018 8
2019 9
2020 17
2021 23
2022 19
2023 15
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

541 results

Results by year

Filters applied: . Clear all
Page 1
Gestational Trophoblastic Disease: Current Evaluation and Management.
Soper JT. Soper JT. Obstet Gynecol. 2021 Feb 1;137(2):355-370. doi: 10.1097/AOG.0000000000004240. Obstet Gynecol. 2021. PMID: 33416290 Free PMC article. Review.
This review summarizes the current evaluation and management of gestational trophoblastic disease, including evacuation of hydatidiform moles, surveillance after evacuation of hydatidiform mole and the diagnosis and management of gestational trophoblastic neo …
This review summarizes the current evaluation and management of gestational trophoblastic disease, including evacuation of hydatidiform …
The hydatidiform mole.
Candelier JJ. Candelier JJ. Cell Adh Migr. 2016 Mar 3;10(1-2):226-35. doi: 10.1080/19336918.2015.1093275. Epub 2015 Sep 30. Cell Adh Migr. 2016. PMID: 26421650 Free PMC article. Review.
The hydatidiform mole (HM) is a placental pathology of androgenetic origin. ...The destruction/expulsion of the female pronucleus at the time of fertilization by 1 or 2 spermatozoa with the former being followed by an endoreplication of the male pronucleus leading t …
The hydatidiform mole (HM) is a placental pathology of androgenetic origin. ...The destruction/expulsion of the female pronucl …
Advances in diagnostics and management of gestational trophoblastic disease.
Lukinovic N, Malovrh EP, Takac I, Sobocan M, Knez J. Lukinovic N, et al. Radiol Oncol. 2022 Oct 27;56(4):430-439. doi: 10.2478/raon-2022-0038. eCollection 2022 Dec 1. Radiol Oncol. 2022. PMID: 36286620 Free PMC article. Review.
The malignant tumours specifically are commonly referred to as gestational trophoblastic neoplasia (GTN). They consist of invasive mole, choriocarcinoma, placental-site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). ...
The malignant tumours specifically are commonly referred to as gestational trophoblastic neoplasia (GTN). They consist of invasive mole …
Gestational trophoblastic disease: an update.
Chawla T, Bouchard-Fortier G, Turashvili G, Osborne R, Hack K, Glanc P. Chawla T, et al. Abdom Radiol (NY). 2023 May;48(5):1793-1815. doi: 10.1007/s00261-023-03820-5. Epub 2023 Feb 10. Abdom Radiol (NY). 2023. PMID: 36763119 Review.
There is a wide geographic variation with the incidence of hydatidiform mole varying between 0.57 and 2 per 1000 pregnancies. The use of ultrasound (US) in the management of early pregnancy symptoms and complications has positively impacted the earlier detection of …
There is a wide geographic variation with the incidence of hydatidiform mole varying between 0.57 and 2 per 1000 pregnancies. …
Pathology of gestational trophoblastic disease (GTD).
Kaur B. Kaur B. Best Pract Res Clin Obstet Gynaecol. 2021 Jul;74:3-28. doi: 10.1016/j.bpobgyn.2021.02.005. Epub 2021 Mar 31. Best Pract Res Clin Obstet Gynaecol. 2021. PMID: 34219021 Review.
Gestational trophoblastic disease (GTD) is subclassified into hydatidiform mole (HM), gestational trophoblastic tumours (GTT) and non-neoplastic trophoblastic lesions. ...
Gestational trophoblastic disease (GTD) is subclassified into hydatidiform mole (HM), gestational trophoblastic tumours (GTT) …
Guideline No. 408: Management of Gestational Trophoblastic Diseases.
Eiriksson L, Dean E, Sebastianelli A, Salvador S, Comeau R, Jang JH, Bouchard-Fortier G, Osborne R, Sauthier P. Eiriksson L, et al. J Obstet Gynaecol Can. 2021 Jan;43(1):91-105.e1. doi: 10.1016/j.jogc.2020.03.001. J Obstet Gynaecol Can. 2021. PMID: 33384141 Review.
EVIDENCE: Relevant studies from 2002 onwards were searched in Embase, MEDLINE, the Cochrane Central Register of Controlled Trials, and Cochrane Systematic Reviews using the following terms, either alone or in combination: trophoblastic neoplasms, choriocarcinoma, trophoblastic tu …
EVIDENCE: Relevant studies from 2002 onwards were searched in Embase, MEDLINE, the Cochrane Central Register of Controlled Trials, and Cochr …
Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
Lurain JR. Lurain JR. Am J Obstet Gynecol. 2010 Dec;203(6):531-9. doi: 10.1016/j.ajog.2010.06.073. Epub 2010 Aug 21. Am J Obstet Gynecol. 2010. PMID: 20728069 Review.
Gestational trophoblastic disease includes hydatidiform mole (complete and partial) and gestational trophoblastic neoplasia (invasive mole, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor). The epidemiology, pathology, …
Gestational trophoblastic disease includes hydatidiform mole (complete and partial) and gestational trophoblastic neoplasia (i …
COVID-19 and hydatidiform mole.
Abbas AM, Ahmed L, Salem AS, Elsamman SH, Refai A, Fathy SK, Ahmed OA, Shalotut AS, AbdelWahab RA. Abbas AM, et al. Am J Reprod Immunol. 2020 Nov;84(5):e13310. doi: 10.1111/aji.13310. Epub 2020 Aug 4. Am J Reprod Immunol. 2020. PMID: 32698238 Free PMC article. Review.
Pregnant patients with COVID-19 had immune dysregulation that could result in abnormal pregnancy outcomes such as hydatidiform mole (HM), recurrent pregnancy loss, and early-onset preeclampsia. ...
Pregnant patients with COVID-19 had immune dysregulation that could result in abnormal pregnancy outcomes such as hydatidiform mol …
Clinical and genetic-epignetic aspects of recurrent hydatidiform mole: A review of literature.
Moein-Vaziri N, Fallahi J, Namavar-Jahromi B, Fardaei M, Momtahan M, Anvar Z. Moein-Vaziri N, et al. Taiwan J Obstet Gynecol. 2018 Feb;57(1):1-6. doi: 10.1016/j.tjog.2017.12.001. Taiwan J Obstet Gynecol. 2018. PMID: 29458875 Free article. Review.
Hydatidiform Mole (HM) is the most common form of Gestational Trophoblastic Disease (GTD), defined by hyper-proliferation of trophoblastic cells. HM is typified as abnormal proliferation of extraembryonic trophoblastic (placental) tissues and failure of embryonic ti …
Hydatidiform Mole (HM) is the most common form of Gestational Trophoblastic Disease (GTD), defined by hyper-proliferation of t …
Triploid pregnancy-Clinical implications.
Massalska D, Bijok J, Kucińska-Chahwan A, Zimowski JG, Ozdarska K, Panek G, Roszkowski T. Massalska D, et al. Clin Genet. 2021 Oct;100(4):368-375. doi: 10.1111/cge.14003. Epub 2021 Jun 1. Clin Genet. 2021. PMID: 34031868 Review.
Molecular confirmation of the parental origin allows to predict the risk of complications, such as gestational trophoblastic neoplasia, hyperthyroidism, hypertension, or preeclampsia associated with the paternal origin of triploidy. Diagnosis of partial hydatidiform mol …
Molecular confirmation of the parental origin allows to predict the risk of complications, such as gestational trophoblastic neoplasia, hype …
541 results